1.
Balapradhana Santoso J. Cost Effectiveness Analysis Trastuzumab Deruxtecan Versus Trastuzumab Emtansine Pada Pasien Kanker Payudara Metastatik Her2-Positif: Systematic Review. IJHET [Internet]. 2026 Mar. 25 [cited 2026 Mar. 27];4(6). Available from: https://afdifaljournal.com/journal/index.php/ijhet/article/view/649